-
平臺(tái)編號(hào)：bio-69639
-
國(guó)際編號(hào)：PCS-200-011
-
細(xì)胞信息： Homo sapiens (human)
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
Homo sapiens (human)
是否是腫瘤細(xì)胞：0
物種來源：人
年限：Adult
細(xì)胞形態(tài)：其他
ATCC Number：PCS-200-011
運(yùn)輸方式：凍存運(yùn)輸
數(shù)量：大量
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
規(guī)格：0.1ml Name: Primary Epidermal Keratinocytes; Normal, Human, Adult
Biosafety Level:1
Shipped: frozen
Organism: Homo sapiens (human)
Source: Skin (epidermis)
Growth Properties: Adherent
Age: Adult
Morphology: Cobblestone appearance; cells are rounded, not flat
Volume per Vial: 1 ml
Ethnicity: Lot-specific
Gender: Lot-specific
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Products:Primary Epidermal Keratinocytes; Normal, Human, Neonatal Foreskin (ATCC PCS-200-010 )
Dermal Cell Basal Medium (ATCC PCS-200-030 )
Keratinocyte Growth Kit (ATCC PCS-200-040 )
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC 30-2200 )
Trypsin-EDTA for Primary Cells (ATCC PCS-999-003 )
Trypsin Neutralizing Solution (ATCC PCS-999-004 )
Gentamicin-Amphotericin B Solution (ATCC PCS-999-025 )
Penicillin-Streptomycin-Amphotericin B Solution (ATCC PCS-999-002 )
Phenol Red (ATCC PCS-999-001 )
Recomended Culture Conditions:See Product Information Sheet Comments:A complete solution to propagate keratinocytes isolated from human skin. The serum-free media is formulated to inhibit fibroblast growth, and the low calcium concentration (60 μM) slows differentiation. No feeder layers, extracellular matrix proteins or other substrates are required.
Applications:Toxicology, wound repair, skin cancer, response to UV radiation, psoriasis, eczema, viral infection, gene delivery systems, cellular differentiation, cosmetics research/testing
Viability:≥ 50%
Population Doubling Capacity:≥ 15 in complete growth medium
Sterility Tests: Bacteria and Yeast: Negative
Mycoplasma: Negative
Testing: Hepatitis B: Negative
Hepatitis C: Negative
HIV: Negative
物種來源：人
年限：Adult
細(xì)胞形態(tài)：其他
ATCC Number：PCS-200-011
運(yùn)輸方式：凍存運(yùn)輸
數(shù)量：大量
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
規(guī)格：0.1ml Name: Primary Epidermal Keratinocytes; Normal, Human, Adult
Biosafety Level:1
Shipped: frozen
Organism: Homo sapiens (human)
Source: Skin (epidermis)
Growth Properties: Adherent
Age: Adult
Morphology: Cobblestone appearance; cells are rounded, not flat
Volume per Vial: 1 ml
Ethnicity: Lot-specific
Gender: Lot-specific
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Products:Primary Epidermal Keratinocytes; Normal, Human, Neonatal Foreskin (ATCC PCS-200-010 )
Dermal Cell Basal Medium (ATCC PCS-200-030 )
Keratinocyte Growth Kit (ATCC PCS-200-040 )
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC 30-2200 )
Trypsin-EDTA for Primary Cells (ATCC PCS-999-003 )
Trypsin Neutralizing Solution (ATCC PCS-999-004 )
Gentamicin-Amphotericin B Solution (ATCC PCS-999-025 )
Penicillin-Streptomycin-Amphotericin B Solution (ATCC PCS-999-002 )
Phenol Red (ATCC PCS-999-001 )
Recomended Culture Conditions:See Product Information Sheet Comments:A complete solution to propagate keratinocytes isolated from human skin. The serum-free media is formulated to inhibit fibroblast growth, and the low calcium concentration (60 μM) slows differentiation. No feeder layers, extracellular matrix proteins or other substrates are required.
Applications:Toxicology, wound repair, skin cancer, response to UV radiation, psoriasis, eczema, viral infection, gene delivery systems, cellular differentiation, cosmetics research/testing
Viability:≥ 50%
Population Doubling Capacity:≥ 15 in complete growth medium
Sterility Tests: Bacteria and Yeast: Negative
Mycoplasma: Negative
Testing: Hepatitis B: Negative
Hepatitis C: Negative
HIV: Negative
